Roberto Weiser
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Botulinum Toxin and Related Neurological Disorders
-
- Multiple Sclerosis Research Studies
Papers in
-
- Parkinson's Disease Mechanisms and Treatments 7
- Neurological disorders and treatments 1
- Botulinum Toxin and Related Neurological Disorders 1
-
- Multiple Sclerosis Research Studies 5
- Co-authors
- Melissa Hanson (4 shared papers)Marisol Gallardo (4 shared papers)Andrew Singleton (4 shared papers)Katrina A. Gwinn (3 shared papers)Amanda Singleton (3 shared papers)Dena G. Hernandez (3 shared papers)Bernard M. Ravina (2 shared papers)John Hardy (2 shared papers)
- Journals
- Multiple Sclerosis and Related Disorders (3 papers)Neurology (2 papers)Behavioural Pharmacology (1 paper)Clinical Neuropharmacology (1 paper)Movement Disorders (1 paper)
- Partner nations
- United StatesSpainVenezuela
In The Last Decade
Roberto Weiser
17 papers receiving 616 citations
Peers
Comparison fields: 5 of 51
- Neurology 409
- Pathology and Forensic Medicine 86
- Cellular and Molecular Neuroscience 59
- Physiology 68
- Endocrinology, Diabetes and Metabolism 21
Countries citing papers authored by Roberto Weiser
This map shows the geographic impact of Roberto Weiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Weiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Weiser more than expected).
Fields of papers citing papers by Roberto Weiser
This network shows the impact of papers produced by Roberto Weiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Weiser. The network helps show where Roberto Weiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Weiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 206 | |
| 2 | 1999 | 90 | |
| 3 | 2005 | 61 | |
| 4 | 2004 | 60 | |
| 5 | 1994 | 44 | |
| 6 | 2005 | 38 | |
| 7 | 2021 | 38 | |
| 8 | 2021 | 35 | |
| 9 | Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease. | 1978 | 16 |
| 10 | 1995 | 13 | |
| 11 | 2003 | 13 | |
| 12 | 2022 | 12 | |
| 13 | 2013 | 8 | |
| 14 | 2011 | 5 | |
| 15 | 2024 | 3 | |
| 16 | 2025 | 2 | |
| 17 | CLINICAL FEATURES OF YOUNG ONSET PARKINSON'S DISEASE | 2009 | 1 |
About Roberto Weiser
Roberto Weiser is a scholar working on Neurology, Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, Neurology and Endocrinology, Diabetes and Metabolism, having authored 17 papers that have together received 645 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (7 papers), Multiple Sclerosis Research Studies (5 papers), Genetic Neurodegenerative Diseases (3 papers), Lysosomal Storage Disorders Research (1 paper), COVID-19 Clinical Research Studies (1 paper), Neurological and metabolic disorders (1 paper), Neurological disorders and treatments (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Neurology (409 citations), Pathology and Forensic Medicine (86 citations), Cellular and Molecular Neuroscience (59 citations), Physiology (68 citations) and Endocrinology, Diabetes and Metabolism (21 citations). Roberto Weiser has collaborated with scholars based in United States, Spain and Venezuela. Frequent co-authors include Melissa Hanson, Marisol Gallardo, Andrew Singleton, Katrina A. Gwinn, Amanda Singleton, Dena G. Hernandez, Bernard M. Ravina, John Hardy, Vincenzo Bonifati and Anthony E. Lang. Their work appears in journals such as Multiple Sclerosis and Related Disorders, Neurology, Behavioural Pharmacology, Clinical Neuropharmacology and Movement Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.